pharmaphorum

AUGUST 6, 2021

There was a dramatic increase in the launch of health-related mobile applications last year, taking the total number on offer in app stories to 350,000 – and while average quality is currently “middling” it is on the rise, according to a report from IQVIA. The pandemic contributed to another 90,000 apps being introduced in 2020 – an average of 250 per day – and this coupled with rising number and functionality of wearable devices “provides evidence of digital health’s acc

Diabetes 145

Diabetes 145

Outsourcing Pharma

AUGUST 5, 2021

A leader from the clinical research tech specialist explains how the use of AI is increasing in the field and outlines the many ways it could SOMETHING.

145

145

NY Times

AUGUST 3, 2021

The Food and Drug Administration’s move is expected to kick off more vaccination mandates for hospital workers, college students and federal troops.

Vaccines 145

Vaccines Hospitals Immunity Immunization 145

Pharma Times

AUGUST 4, 2021

Sativex is a complex botanical formulation that contains the principal cannabinoids THC and CBD

158

158

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

pharmaphorum

AUGUST 4, 2021

Spinal Muscular Atrophy (SMA) is a rare disease affecting the motor nerve cells in the spinal cord. It’s a debilitating condition that affects 1 per 8,000 to 10,000 people worldwide , impacting their ability to walk, eat, and breathe. SMA Type 1 represents an estimated 50% of all cases, for which life expectancy is less than 18 months without treatment. .

145

145

Outsourcing Pharma

AUGUST 3, 2021

A leader from the company says to ensure medicines keep reaching the patients that need them, the industry must revamp outdated technologies and techniques.

130

130

Pharma Times

AUGUST 6, 2021

The finalists have been confirmed for the 2021 Clinical Researcher of the Year – The Americas competition.

123

123

pharmaphorum

AUGUST 5, 2021

Protein-protein interactions (PPIs) are becoming increasingly relevant in the pathology of many diseases, including cancer. The issue, however, is developing an effective way of targeting them. . The latest advancements in methods targeting PPIs are designed to overcome the challenges limiting the conventional methods. Targeting PPIs offers another potential therapeutic target for diseases with complex biological profiles.

Compounding 123

Compounding Chemotherapy Drug Development 123

Outsourcing Pharma

AUGUST 3, 2021

The Psychae Institute, established by a global team of scientists, will conduct pre-clinical and clinical research around psychedelic medicine development.

130

130

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for RIOMET Riomet is a drug marketed by Ranbaxy and Sun Pharm and is included in two NDAs. It is available from one supplier. There are…. The post New patent expiration for Ranbaxy drug RIOMET appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Pharma Times

AUGUST 3, 2021

The study will be the largest clinical trial of its kind in the UK, involving over 600 pregnant women

Vaccines 129

Vaccines 129

pharmaphorum

AUGUST 4, 2021

Fresenius has launched a virtual reality based training programme for people undergoing home dialysis in Germany, its home market, ahead of a rollout in other countries later this year. The VR system – called stay•safe MyTraining VR – is designed for use in patients undergoing peritoneal dialysis, which uses the peritoneum in a person’s abdomen as the membrane through which fluid and dissolved substances are exchanged with the blood.

Diabetes 109

Diabetes 109

Outsourcing Pharma

AUGUST 2, 2021

According to the neurodegenerative-disease-focused biotechnology firm, their research could bring hope to patients with amyotrophic lateral sclerosis.

119

119

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for IMVEXXY Imvexxy is a drug marketed by Therapeuticsmd Inc and is included in one NDA. It is available from one supplier. There are eleven patents…. The post New patent for Therapeuticsmd Inc drug IMVEXXY appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 3, 2021

Tecentriq is first and only cancer immunotherapy with positive Phase III results in adjuvant lung cancer setting

120

120

pharmaphorum

AUGUST 6, 2021

Moderna made a massive $4.2 billion from sales of just under 200 million doses of its COVID-19 vaccine, taking its tally since approval to around $6 billion from 302 million shots. The tally makes the SpikeVax (mRNA-1273) vaccine the second biggest seller behind Pfizer/BioNTech’s Comirnaty, which pulled in $7.8 billion in the second quarter and $11.3 billion since the start of the year.

Vaccines 104

Vaccines Immunity Immunization 104

Outsourcing Pharma

AUGUST 3, 2021

The success of mRNA vaccine technology could be one of the new opportunities for US pharmaceutical manufacturing looking forward, with pandemic investments helping turbocharge the sector.

Pharmaceutical Manufacturing 108

Pharmaceutical Manufacturing Vaccines 108

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for ARMONAIR+DIGIHALER Armonair Digihaler is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are twenty-two…. The post New patent for Teva Pharm drug ARMONAIR DIGIHALER appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 2, 2021

Saphnelo is the first type I interferon receptor agonist to receive regulatory approval

134

134

pharmaphorum

AUGUST 6, 2021

Patient enrollment is a common issue across many therapeutic areas in clinical research. Psychiatric disorders in particular represent a trial area with significantly high drop-out rates and poor patient recruitment. The reasons behind this problem, however, are rarely studied or understood. Despite this, new strategies devised over the last five years are beginning to reverse the trend, and both reduce stigma and increase awareness to funnel new patients into these important trials. .

Hospitals 104

Hospitals Communication 104

Outsourcing Pharma

AUGUST 2, 2021

Arcturus Therapeutics and its Vietnam partner Vinbiocare will take ARCT-154, a next-generation Arcturus vaccine targeting SARS-CoV-2 variants of concern, into a Phase 1/2/3 trial. The companies will also establish a vaccine manufacturing centre in Vietnam.

Vaccines 105

Vaccines 105

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for ARMONAIR+RESPICLICK Armonair Respiclick is a drug marketed by Teva Pharm and is included in one NDA. It is available from one supplier. There are nineteen…. The post New patent for Teva Pharm drug ARMONAIR RESPICLICK appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 6, 2021

UK Competition and Markets Authority provisionally finds drug companies broke competition law

121

121

pharmaphorum

AUGUST 3, 2021

The FDA has relaxed a clinical hold on clinical trials of Novartis’ intrathecal formulation of spinal muscular atrophy (SMA) gene therapy Zolgensma, allowing a new phase 3 trial to get underway. Zolgensma (onasemnogene abeparvovec) is already approved as an intravenous treatment in babies and very young children for the rare muscle-wasting disease, but the new OAV-101 IT version is designed to unlock use of the drug in older SMA patients.

104

104

Outsourcing Pharma

AUGUST 4, 2021

An industry study from the producer of CPhI North America shows the pandemic and other factors are contributing to a very dynamic pharmaceutical market.

105

105

Drug Patent Watch

AUGUST 6, 2021

Annual Drug Patent Expirations for NOURESS Nouress is a drug marketed by Baxter Hlthcare Corp and is included in one NDA. There are eleven patents protecting this drug. Drug patent…. The post New patent for Baxter Hlthcare drug NOURESS appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 5, 2021

Agreement will support use of the 'best evidence-based healthcare' in the NHS

129

129

pharmaphorum

AUGUST 2, 2021

Ipsen’s new chief executive David Loew pledged to ramp up spending on the company’s pipeline when he took the helm last year, and a flurry of licensing deals in the last few weeks shows that push is starting to gather momentum. The French company – which focusing on cancer, neuroscience and rare diseases – has just snapped up two programmes from US biotech Exicure that span the latter two areas, targeted at rare neurodegenerative disorders Huntington’s disease and Angelman synd

102

102

Outsourcing Pharma

AUGUST 2, 2021

The drug, intended for adult patients with moderate-to-severe systemic lupus erythematosus, is the only new therapy approved for SLE in more than a decade.

98

98

Drug Patent Watch

AUGUST 5, 2021

Annual Drug Patent Expirations for ORKAMBI Orkambi is a drug marketed by Vertex Pharms Inc and is included in two NDAs. It is available from one supplier. There are nineteen…. The post New patent for Vertex Pharms drug ORKAMBI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 3, 2021

The £100m fine sends ‘a clear message’ to the pharma sector, said the CMA

123

123

pharmaphorum

AUGUST 4, 2021

The need for automated metadata management software has never been greater. The number of global clinical trials being run is increasing every year. And, they are becoming increasingly complex to manage. There’s a vast amount of data that needs to be collected and analyzed. There are more regulations in place than ever before and industry standards are constantly being updated.

Communication 98

Communication Documentation 98

Outsourcing Pharma

AUGUST 3, 2021

Adoption of single-use technologies has grown exponentially over the last decade: but what will drive the tech forward in the coming years?

98

98

Drug Patent Watch

AUGUST 5, 2021

Annual Drug Patent Expirations for GOCOVRI Gocovri is a drug marketed by Adamas Pharma and is included in one NDA. It is available from one supplier. There are fifteen patents…. The post New patent for Adamas Pharma drug GOCOVRI appeared first on DrugPatentWatch - Make Better Decisions.

52

52

Pharma Times

AUGUST 6, 2021

Libtayo plus platinum-doublet chemotherapy led to a 29% reduction in risk of death compared to chemotherapy alone

Chemotherapy 106

Chemotherapy 106